Gene expression dose-response of liver with a genotoxic and nongenotoxic carcinogen.

Int J Toxicol

Toxicology and Environmental Research and Consulting, The Dow Chemical Company, Midland, Michigan 48674, USA.

Published: April 2006

Tumorigenic mechanisms due to chemical exposure are broadly classified as either genotoxic or nongenotoxic. Genotoxic mechanisms are generally well defined; however nongenotoxic modes of tumorgenesis are less straightforward. This study was undertaken to help elucidate dose-response changes in gene expression (transcriptome) in the liver of rats in response to administration of known genotoxic or nongenotoxic liver carcinogens. Male Big Blue Fischer 344 rats were treated for 28-days with 0, 0.1, 0.3, 1.0, or 3.0 mg/kg/day of the genotoxin 2-acetylaminofluorene (AAF) or 0, 10, 30, 60, or 100 mg/kg/day of the nongenotoxin phenobarbital (PB). Transcriptome analysis was performed using the relatively focused Clontech Rat Toxicology II microarray (465 genes) and hybridized with 32P-labeled cDNA target. The analysis indicated that after 28 days of treatment, AAF altered the expression of 14 genes (9 up- and 5 down-regulated) and PB altered the expression of 18 genes (10 up- and 8 down-regulated). Of the limited genes whose expression was altered by AAF and PB, four were altered in common, two up-regulated, and two down-regulated. Several of the genes that show modulation of transcriptional activity following AAF and PB treatment display an atypical dose-response relationship such that the expression at the higher doses tended to be similar to that of control. This high-dose effect could potentially be caused by adaptation, toxicity, or tissue remodeling. These results suggest that the transcriptional response of the cells to higher doses of a toxic agent is likely to be different from that of a low-dose exposure.

Download full-text PDF

Source
http://dx.doi.org/10.1080/10915810500488429DOI Listing

Publication Analysis

Top Keywords

genotoxic nongenotoxic
12
gene expression
8
aaf altered
8
altered expression
8
expression genes
8
genes up-
8
up- down-regulated
8
higher doses
8
expression
5
genes
5

Similar Publications

Background: Previously, Japanese Environmental Mutagen and Genome Society/Mammalian Mutagenicity Study Group/Toxicogenomics Study Group (JEMS/MMS toxicogenomic study group) proposed 12 genotoxic marker genes (Aen, Bax, Btg2, Ccnf, Ccng1, Cdkn1a, Gdf15, Lrp1, Mbd1, Phlda3, Plk2, and Tubb4b) to discriminate genotoxic hepatocarcinogens (GTHCs) from non-genotoxic hepatocarcinogens (NGTHCs) and non-genotoxic non-hepatocarcinogens (NGTNHCs) in mouse and rat liver using qPCR and RNA-Seq and confirmed in public rat toxicogenomics data, Open TG-GATEs, by principal component analysis (PCA). On the other hand, the U.S.

View Article and Find Full Text PDF

Background: When assessing the genotoxicity of substances containing probiotic candidates, such as lactic acid-producing bacteria, using the in vitro micronucleus test (MNT), bacterial growth in the test medium may reduce the pH of the medium. The low medium pH is known to induce cytotoxicity and false-positive results. In the TK6 cell system, it is difficult to completely remove the bacteria from the medium by washing post-treatment, leading to bacterial growth during the recovery period in the short-term treatment.

View Article and Find Full Text PDF

Genotoxic and antigenotoxic medicinal plant extracts and their main phytochemicals: "A review".

Front Pharmacol

November 2024

Laboratory of Dietetics and Clinical Nutrition, Department of Public Health, Experimental and Forensic Medicine, University of Pavia, Pavia, Italy.

Many medicinal plant extracts have been proven to have significant health benefits. In contrast, research has shown that some medicinal plant extracts can be toxic, genotoxic, mutagenic, or carcinogenic. Therefore, evaluation of the genotoxicity effects of plant extracts that are used as traditional medicine is essential to ensure they are safe for use and in the search for new medication.

View Article and Find Full Text PDF

Assessment of genotoxicity and acute oral toxicity of a standardized extract (Holixer).

Drug Chem Toxicol

November 2024

Department of Biology, R&D Centre, Natural Remedies Private Limited, Bengaluru, Karnataka, India.

Article Synopsis
  • Holy basil, also known as Tulsi, is valued for its health benefits in traditional medicine systems like Ayurveda, which include anti-inflammatory and antioxidant properties.
  • A scientific study assessed the safety of a standardized extract of Tulsi through various tests, including genotoxicity studies and an acute oral toxicity study on animal models.
  • The results indicated that the Tulsi extract is non-genotoxic and safe for oral consumption in doses up to 5000 mg/kg body weight in rats.
View Article and Find Full Text PDF

The incidence of multiple-organ cancers has recently increased due to simultaneous exposure to various environmental carcinogens. Thunb. () is recognized for its many health benefits, including its anti-cancer properties.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!